Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mitzi J Williams"'
Autor:
Laura Airas, Robert A. Bermel, Tanuja Chitnis, Hans-Peter Hartung, Jin Nakahara, Olaf Stuve, Mitzi J. Williams, Bernd C. Kieseier, Heinz Wiendl
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Bruton’s tyrosine kinase (BTK) inhibitors are an emerging class of therapeutics in multiple sclerosis (MS). BTK is expressed in B-cells and myeloid cells, key progenitors of which include dendritic cells, microglia and macrophages, integral effecto
Externí odkaz:
https://doaj.org/article/e3efcb2e0b04417cb13665a1b2416894
Autor:
Mitzi J. Williams, Lilyana Amezcua, Angel Chinea, Stanley Cohan, Annette Okai, Darin T. Okuda, Wendy Vargas, Nick Belviso, Ivan Božin, Xiaotong Jiang, James B. Lewin, Jennifer Lyons, Changyu Shen, Sarah M. England, Nydjie Grimes
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1669-1682 (2023)
Abstract Introduction Multiple sclerosis (MS) clinical trials have included low numbers of patients from racial and ethnic minority populations; therefore, it is uncertain whether differences exist in response to disease-modifying therapies. We evalu
Externí odkaz:
https://doaj.org/article/2c2b0b4ff387415eaeb5b39904d4d74c
Autor:
Mitzi J. Williams, Lilyana Amezcua, Annette Okai, Darin T. Okuda, Stanley Cohan, Ray Su, Becky Parks, Jason P. Mendoza, James B. Lewin, Cynthia C. Jones
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 483-493 (2020)
Abstract Introduction Black or African American (black/AA) patients with multiple sclerosis (MS) are reported to exhibit greater disease severity compared with non-black or non-AA patients. Whether differences exist in response to MS disease-modifyin
Externí odkaz:
https://doaj.org/article/85d7a4d0f6eb4477bc4ce8aec51e644c
Autor:
Angel Chinea, Lilyana Amezcua, Wendy Vargas, Annette Okai, Mitzi J. Williams, Ray Su, Becky Parks, Jason P. Mendoza, James B. Lewin, Cynthia C. Jones
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 495-504 (2020)
Abstract Introduction Compared with the non-Hispanic/non-Latino population, Hispanic/Latino patients with multiple sclerosis (MS) are reported to exhibit greater disease severity. Geographical location and genetics play a role in differences observed
Externí odkaz:
https://doaj.org/article/628eae7e81094885992adf0e786a8a07
Autor:
Annette F. Okai, Lilyana Amezcua, Regina R. Berkovich, Angel R. Chinea, Keith R. Edwards, Brian Steingo, Aljoeson Walker, Alan K. Jacobs, Nadia Daizadeh, Mitzi J. Williams, the CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators
Publikováno v:
Neurology and Therapy, Vol 8, Iss 2, Pp 367-381 (2019)
Abstract Introduction Multiple sclerosis (MS) patients of African descent have increased risk for disease progression and may be less responsive to disease-modifying therapy. Methods Patients in the CARE-MS studies received alemtuzumab 12 mg/day [ini
Externí odkaz:
https://doaj.org/article/3c88f76d51334febbab539a6097228c0
Autor:
Annette F. Okai, Annette M. Howard, Mitzi J. Williams, Justine D. Brink, Chiayi Chen, Tamela L. Stuchiner, Elizabeth Baraban, Grace Jeong, Stanley L. Cohan
Publikováno v:
Neurology. 98:1015-1020
Multiple sclerosis (MS) has historically been underdiagnosed and undertreated among African Americans. Recent evidence suggests that African Americans with MS have a different clinical presentation, increased disease incidence and burden, and worse l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f82b771c9eac15ebcbcb54b7bad5e5de
https://doi.org/10.1212/wnl.0000000000200791
https://doi.org/10.1212/wnl.0000000000200791
Publikováno v:
Neurology and Therapy
Graphical Plain Language Summary COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8043de885b6b3c449e4a770ec83dc101
https://doi.org/10.1007/s40120-021-00266-z
https://doi.org/10.1007/s40120-021-00266-z
Autor:
Monique LaRocque, April Moreno, Mitzi J. Williams, Shawn Feliciano, Daniela A. Pimentel Maldonado, Melissa Glim, Daniel Machemer, Terrie Livingston, Hollie Schmidt, Anita Williams, Lilyana Amezcua
Publikováno v:
Int J MS Care
Background: For unclear reasons, minorities have been historically underrepresented in multiple sclerosis (MS) clinical trials. We hypothesized that different perceptions and preferences about research participation among racial and ethnic groups con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2ab5b3cdbadb18a8e1c02b0414036eb
https://doi.org/10.7224/1537-2073.2019-131
https://doi.org/10.7224/1537-2073.2019-131
Autor:
Becky Parks, Darin T. Okuda, James B. Lewin, Jason P. Mendoza, Stanley Cohan, Lilyana Amezcua, Mitzi J. Williams, Ray Su, Cynthia C. Jones, Annette Okai
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 483-493 (2020)
Neurology and Therapy
Neurology and Therapy
Introduction Black or African American (black/AA) patients with multiple sclerosis (MS) are reported to exhibit greater disease severity compared with non-black or non-AA patients. Whether differences exist in response to MS disease-modifying therapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ac439d11db8f7b0391021f6c8eb2e8
https://doi.org/10.1007/s40120-020-00193-5
https://doi.org/10.1007/s40120-020-00193-5
Autor:
Becky Parks, Wendy Vargas, Cynthia C. Jones, Jason P. Mendoza, James B. Lewin, Lilyana Amezcua, Ray Su, Annette Okai, Angel Chinea, Mitzi J. Williams
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 495-504 (2020)
Neurology and Therapy
Neurology and Therapy
Introduction Compared with the non-Hispanic/non-Latino population, Hispanic/Latino patients with multiple sclerosis (MS) are reported to exhibit greater disease severity. Geographical location and genetics play a role in differences observed across H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fce062e837c35dd35c82142fb794cf9
https://doaj.org/article/628eae7e81094885992adf0e786a8a07
https://doaj.org/article/628eae7e81094885992adf0e786a8a07